Evaluating the Role of SARS-CoV-2 Antibody Levels in the Care of Long COVID Patients Infected with the Omicron Variant - Top-Institutions - MDSpire

Evaluating the Role of SARS-CoV-2 Antibody Levels in the Care of Long COVID Patients Infected with the Omicron Variant

  • By

  • Marina Kawaguchi

  • Yasue Sakurada

  • Kazuki Tokumasu

  • Yuki Otsuka

  • Yasuhiro Nakano

  • Yui Matsuda

  • Hiroyuki Honda

  • Daisuke Omura

  • Nobuyoshi Matsuki

  • Masanori Furukawa

  • Akihito Higashikage

  • Fumio Otsuka

  • April 22, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Post-Acute COVID-19 Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Neurology
    • Post-COVID Care

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Neurology
    • Post-Acute Care

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Post-COVID Syndrome

  • #5

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Post-COVID Care

Original Source(s)

Evaluating the Role of SARS-CoV-2 Antibody Levels in the Care of Long COVID Patients Infected with the Omicron Variant

  • by Marina Kawaguchi, Yasue Sakurada, Kazuki Tokumasu, Yuki Otsuka, Yasuhiro Nakano, Yui Matsuda, Hiroyuki Honda, Daisuke Omura, Nobuyoshi Matsuki, Masanori Furukawa, Akihito Higashikage, Fumio Otsuka

  • April 22, 2026

Related Content

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.

COVID-19, Vaccines, and Retinal Vascular Disease

A global systematic review of 173 studies found differing associations between COVID-19 infection and vaccination and retinal vascular events, with retinal artery occlusion more common after infection and retinal vein occlusion more common after vaccination.